Covid-19: US sends consignment carrying 545 oxygen concentrators to India

The fifth in a series of consignments carrying 545 oxygen concentrators arrived from the United States on Tuesday, as part of Covid-19 assistance

Topics
Coronavirus | Coronavirus Vaccine | US India relations

ANI  |  US 

The fifth in a series of consignments carrying 545 oxygen concentrators arrived from the United States on Tuesday, as part of COVID-19 assistance.

"5th in a series of consignments carrying medical equipment arrives from the US. This one carrying 545 oxygen concentrators. Appreciate the support from the US," Arindam Bagchi, Spokesperson of the Ministry of External Affairs (MEA) said in a tweet.

The United States Department of Defense has said that the final two flights of COVID-19 aid slated for India have been delayed and will reach at least until Wednesday. US Transportation Command on Monday said that the delay is due to maintenance issues.

This comes as India registered a slight dip in COVID-19 cases as it registered 3,68,147 new infections and 3,417 related deaths in the last 24 hours, informed the union health ministry on Monday morning.

On Sunday, a flight from America carrying 1.25 lakh vials of an anti-viral drug Remdesivir landed in India. On Saturday night, a flight from the US, carrying 1,000 oxygen cylinders, regulators and other medical equipment landed in India.

Last week, the US deployed its first two planes carrying the initial emergency relief supplies including oxygen cylinders, regulators, and pulse oximeters generously donated by California, rapid diagnostic tests and N95 masks.

Moreover, the White House had also announced that the US will be delivering medical supplies worth more than USD 100 million in the coming days to India to provide urgent relief as the country battles a new wave of COVID-19 cases.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus
First Published: Tue, May 04 2021. 08:27 IST
RECOMMENDED FOR YOU